Author

Anne Cunniffe Marcy

Observed name: Anne Marcy

Institutions: Stanford Medicine, Stanford University

Observed institutions: Stanford Medicine, University of San Francisco, Stanford University

OpenAlex ID: A5068852018

Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL)

2019 · Liora M Schultz, Lori S Muffly, et al. · Blood · 52

Phase 1 Study of CD19/CD22 Bispecific Chimeric Antigen Receptor (CAR) Therapy in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia (ALL)

2018 · Liora M Schultz, Kara L. Davis, et al. · Blood · 52

Abstract CT031: GD2 CAR T cells mediate clinical activity and manageable toxicity in children and young adults with DIPG and H3K27M-mutated diffuse midline gliomas

2021 · Robbie G. Majzner, Sneha Ramakrishna, et al. · Cancer Research · 8

Epct-14. Gd2 Car T-cells Mediate Clinical Activity and Manageable Toxicity in Children and Young Adults With H3k27m-mutated Dipg and Spinal Cord Dmg

2021 · Robbie Majzner, Sneha Ramakrishna, et al. · Neuro-Oncology · 7

Omic-11. Single Cell Rna Sequencing From the Csf of Subjects With H3k27m+ Dipg/dmg Treated With Gd2 Car T-cellular Therapy

2021 · Aaron Mochizuki, Sneha Ramakrishna, et al. · Neuro-Oncology · 3

The Use of Microbial Cell-Free DNA Next-Generation Sequencing to Differentiate between Cytokine Release Syndrome and Infection in Pediatric Patients Undergoing Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Acute Lymphoblastic Leukemia

2021 · Catherine Aftandilian, Sneha Ramakrishna, et al. · Transplantation and Cellular Therapy

Caring for Those Who Care the Most: Bill Wilson Center Wellness Program Assessment

2015 · Anne Cunniffe Marcy · USF Scholarship Repository (University of San Francisco)

Works count: 7

Citation count: 122

H-index: 4

I10-index: 2